Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes.

IF 2.5 3区 医学 Q2 HEMATOLOGY
Transfusion Pub Date : 2024-07-23 DOI:10.1111/trf.17968
Ken Takigawa, Takahiro Shima, Chiaki Kubara, Shun Akamine, Sae Utsumi, Teruhiko Yoshino, Mariko Minami, Masayasu Hayashi, Yayoi Matsuo, Takuro Kuriyama, Reiko Yoneda, Shuichi Taniguchi, Tetsuya Eto
{"title":"Fatal posterior reversible encephalopathy syndrome after blood transfusion in a patient with myelodysplastic syndromes.","authors":"Ken Takigawa, Takahiro Shima, Chiaki Kubara, Shun Akamine, Sae Utsumi, Teruhiko Yoshino, Mariko Minami, Masayasu Hayashi, Yayoi Matsuo, Takuro Kuriyama, Reiko Yoneda, Shuichi Taniguchi, Tetsuya Eto","doi":"10.1111/trf.17968","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Posterior reversible encephalopathy syndrome (PRES) is known as a transfusion-related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce.</p><p><strong>Case report: </strong>An 88-year-old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin levels improved from 4.6 to 8.0 g/dL and the pleural effusions substantially decreased following six units of red blood cell transfusion and diuretic therapy, a gradual decline in cognitive function and speech reduction was noted. PRES was diagnosed by magnetic resonance imaging of the head. Despite treatment of intensive supportive care, the patient fell into a coma by the 20th day and passed away on the 22nd day. Although the pathophysiological link between blood-transfusion-related PRES and its impact on survival is not fully understood, autopsy findings confirmed the diagnosis of PRES and revealed multiple cerebral hemorrhages that were not detected in earlier imaging studies.</p><p><strong>Conclusion: </strong>This case highlights the importance of vigilant monitoring and management of PRES, especially in high-risk populations such as elderly patients with multiple comorbidities or those with thrombocytopenia. Further studies are needed to elucidate the mechanisms of PRES in patients with hematologic diseases.</p>","PeriodicalId":23266,"journal":{"name":"Transfusion","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/trf.17968","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is known as a transfusion-related complication with typically favorable prognosis and no report fatalities. Pathological evaluation of PRES is also scarce.

Case report: An 88-year-old female with myelodysplastic syndromes (MDS) attended our hospital because of a compression fracture and chronic heart failure with chronic anemia. While her hemoglobin levels improved from 4.6 to 8.0 g/dL and the pleural effusions substantially decreased following six units of red blood cell transfusion and diuretic therapy, a gradual decline in cognitive function and speech reduction was noted. PRES was diagnosed by magnetic resonance imaging of the head. Despite treatment of intensive supportive care, the patient fell into a coma by the 20th day and passed away on the 22nd day. Although the pathophysiological link between blood-transfusion-related PRES and its impact on survival is not fully understood, autopsy findings confirmed the diagnosis of PRES and revealed multiple cerebral hemorrhages that were not detected in earlier imaging studies.

Conclusion: This case highlights the importance of vigilant monitoring and management of PRES, especially in high-risk populations such as elderly patients with multiple comorbidities or those with thrombocytopenia. Further studies are needed to elucidate the mechanisms of PRES in patients with hematologic diseases.

骨髓增生异常综合征患者输血后出现致命的后可逆性脑病综合征。
背景:众所周知,后可逆性脑病综合征(PRES)是一种与输血相关的并发症,通常预后良好,无死亡报告。对 PRES 进行病理评估的病例也很少:一位 88 岁的女性骨髓增生异常综合征(MDS)患者因压缩性骨折和慢性心力衰竭伴慢性贫血到我院就诊。在输注了 6 个单位的红细胞并接受利尿剂治疗后,她的血红蛋白水平从 4.6 克/分升提高到 8.0 克/分升,胸腔积液也大幅减少。经头部磁共振成像检查,确诊为 PRES。尽管患者接受了强化支持治疗,但仍在第 20 天陷入昏迷,并于第 22 天去世。虽然输血相关 PRES 及其对存活的影响之间的病理生理学联系尚未完全明了,但尸检结果证实了 PRES 的诊断,并发现了早期影像学检查未发现的多发性脑出血:本病例强调了对 PRES 进行警惕性监测和管理的重要性,尤其是在高风险人群中,如患有多种并发症的老年患者或血小板减少症患者。需要进一步研究阐明血液病患者发生 PRES 的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Transfusion
Transfusion 医学-血液学
CiteScore
4.70
自引率
20.70%
发文量
426
审稿时长
1 months
期刊介绍: TRANSFUSION is the foremost publication in the world for new information regarding transfusion medicine. Written by and for members of AABB and other health-care workers, TRANSFUSION reports on the latest technical advances, discusses opposing viewpoints regarding controversial issues, and presents key conference proceedings. In addition to blood banking and transfusion medicine topics, TRANSFUSION presents submissions concerning patient blood management, tissue transplantation and hematopoietic, cellular, and gene therapies.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信